ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HIIQ Health Insurance Innovations Inc

27.39
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Health Insurance Innovations Inc NASDAQ:HIIQ NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 27.39 27.30 27.75 0 01:00:00

Current Report Filing (8-k)

14/05/2020 9:06pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 12, 2020

 

Benefytt Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

 Delaware   001-35811   46-1282634

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

3450 Buschwood Park Dr., Suite 200

Tampa, Florida

  33618
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (813) 397-1187

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.001 par value   BFYT   Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

     

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On May 12, 2020, Benefytt Technologies, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The Company previously filed with the SEC its Definitive Proxy Statement and related materials pertaining to the Annual Meeting on April 17, 2020. On the record date of March 30, 2020 there were 13,203,527 shares of the Company’s Class A common stock and 1,016,667 shares of the Company’s Class B common stock outstanding and eligible to vote. At the Annual Meeting, the stockholders: (i) elected the seven persons identified below to serve as directors of the Company to hold office until the Company’s 2021 Annual Meeting of Stockholders and until their successors are duly elected and qualified; (ii) approved, on an advisory basis, the compensation of the Company’s Named Executive Officers; and (iii) ratified the appointment of Grant Thornton LLP as independent auditors of the Company.

 

Proposal 1: Election of Directors

 

The final results of stockholder voting on the election of directors were as follows:

 

Name   Votes For     Votes Withheld     Broker Non-Votes  
Paul E. Avery     5,892,296       150,203       2,872,350  
Anthony J. Barkett     5,741,743       300,756       2,872,350  
John A. Fichthorn     5,917,109       125,390       2,872,350  
Paul G. Gabos     5,941,364       101,135       2,872,350  
Robert S. Murley     5,927,726       114,773       2,872,350  
Peggy B. Scott     5,767,386       275,113       2,872,350  
Gavin D. Southwell     5,961,655       80,844       2,872,350  

 

Proposal 2: Approval of, on an Advisory Basis, Named Executive Officer Compensation

 

The final results of stockholder voting on the approval of, on an advisory basis, the compensation of the Company’s Named Executive Officers were as follows:

 

Votes For     Votes Against     Votes Abstain     Broker Non-Votes  
  5,207,869       823,990       10,639       2,872,351  

 

Proposal 3: To ratify the appointment of Grant Thornton LLP as independent auditors of the Company

 

The final results of stockholder voting to ratify the appointment of Grant Thornton LLP as independent auditors of the Company were as follows:

 

Votes For     Votes Against     Votes Abstain     Broker Non-Votes  
  8,518,608       387,047       9,194        

 

The stockholders did not vote on any other matters during the Annual Meeting.

 

     

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BENEFYTT TECHNOLOGIES, INC.
     
  By: /s/ Erik M. Helding
  Name: Erik M. Helding
  Title: Chief Financial Officer, Secretary and Treasurer

 

Date: May 14, 2020

 

     

 

1 Year Health Insurance Innovat... Chart

1 Year Health Insurance Innovat... Chart

1 Month Health Insurance Innovat... Chart

1 Month Health Insurance Innovat... Chart

Your Recent History

Delayed Upgrade Clock